NL1006305C2 - Werkwijze voor de bereiding van (1S,2R)-1-amino-2-indanol-(R,R)-tartraat methanol solvaat. - Google Patents
Werkwijze voor de bereiding van (1S,2R)-1-amino-2-indanol-(R,R)-tartraat methanol solvaat. Download PDFInfo
- Publication number
- NL1006305C2 NL1006305C2 NL1006305A NL1006305A NL1006305C2 NL 1006305 C2 NL1006305 C2 NL 1006305C2 NL 1006305 A NL1006305 A NL 1006305A NL 1006305 A NL1006305 A NL 1006305A NL 1006305 C2 NL1006305 C2 NL 1006305C2
- Authority
- NL
- Netherlands
- Prior art keywords
- indanol
- amino
- methanol
- tartrate
- preparation
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 28
- 239000012453 solvate Substances 0.000 title claims abstract description 26
- KIXKKIZBNLLSOJ-BGAVDPONSA-N (1s,2r)-1-amino-2,3-dihydro-1h-inden-2-ol;(2r,3r)-2,3-dihydroxybutanedioic acid;methanol Chemical compound OC.OC(=O)[C@H](O)[C@@H](O)C(O)=O.C1=CC=C2[C@H](N)[C@H](O)CC2=C1 KIXKKIZBNLLSOJ-BGAVDPONSA-N 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 111
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- LOPKSXMQWBYUOI-DTWKUNHWSA-N (1r,2s)-1-amino-2,3-dihydro-1h-inden-2-ol Chemical compound C1=CC=C2[C@@H](N)[C@@H](O)CC2=C1 LOPKSXMQWBYUOI-DTWKUNHWSA-N 0.000 claims abstract description 19
- 239000000203 mixture Substances 0.000 claims abstract description 19
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims abstract description 15
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229960001367 tartaric acid Drugs 0.000 claims abstract description 15
- 239000013078 crystal Substances 0.000 claims abstract description 14
- 239000011541 reaction mixture Substances 0.000 claims abstract description 13
- 239000002904 solvent Substances 0.000 claims abstract description 12
- LOPKSXMQWBYUOI-BDAKNGLRSA-N (1s,2r)-1-amino-2,3-dihydro-1h-inden-2-ol Chemical compound C1=CC=C2[C@H](N)[C@H](O)CC2=C1 LOPKSXMQWBYUOI-BDAKNGLRSA-N 0.000 claims abstract description 9
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000002245 particle Substances 0.000 claims abstract description 7
- 238000011084 recovery Methods 0.000 claims abstract description 7
- 239000003112 inhibitor Substances 0.000 claims abstract description 5
- 239000000376 reactant Substances 0.000 claims abstract description 4
- YUOMEKXYCXVZRL-YFQRKTQFSA-N (1r,2s)-1-amino-2,3-dihydro-1h-inden-2-ol;(2r,3r)-2,3-dihydroxybutanedioic acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.C1=CC=C2[C@@H](N)[C@@H](O)CC2=C1 YUOMEKXYCXVZRL-YFQRKTQFSA-N 0.000 claims abstract 2
- 238000006243 chemical reaction Methods 0.000 claims description 5
- NUBQKPWHXMGDLP-UHFFFAOYSA-N 1-[4-benzyl-2-hydroxy-5-[(2-hydroxy-2,3-dihydro-1h-inden-1-yl)amino]-5-oxopentyl]-n-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide;sulfuric acid Chemical compound OS(O)(=O)=O.C1CN(CC(O)CC(CC=2C=CC=CC=2)C(=O)NC2C3=CC=CC=C3CC2O)C(C(=O)NC(C)(C)C)CN1CC1=CC=CN=C1 NUBQKPWHXMGDLP-UHFFFAOYSA-N 0.000 claims description 3
- 229960004243 indinavir sulfate Drugs 0.000 claims description 3
- 238000010612 desalination reaction Methods 0.000 claims description 2
- -1 indanol- (R, R) -tartrate methanol Chemical compound 0.000 claims description 2
- UIQVGMBTAXORQL-UHFFFAOYSA-N 2,3-dihydroxybutanedioic acid;methanol Chemical compound OC.OC(=O)C(O)C(O)C(O)=O UIQVGMBTAXORQL-UHFFFAOYSA-N 0.000 claims 1
- YIAPLDFPUUJILH-UHFFFAOYSA-N indan-1-ol Chemical compound C1=CC=C2C(O)CCC2=C1 YIAPLDFPUUJILH-UHFFFAOYSA-N 0.000 claims 1
- 238000011835 investigation Methods 0.000 claims 1
- 238000009958 sewing Methods 0.000 claims 1
- YUOMEKXYCXVZRL-MHDNXTQBSA-N (1s,2r)-1-amino-2,3-dihydro-1h-inden-2-ol;(2r,3r)-2,3-dihydroxybutanedioic acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.C1=CC=C2[C@H](N)[C@H](O)CC2=C1 YUOMEKXYCXVZRL-MHDNXTQBSA-N 0.000 abstract description 3
- 208000030507 AIDS Diseases 0.000 abstract description 2
- 229960001936 indinavir Drugs 0.000 abstract 1
- CBVCZFGXHXORBI-PXQQMZJSSA-N indinavir Chemical compound C([C@H](N(CC1)C[C@@H](O)C[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H]2C3=CC=CC=C3C[C@H]2O)C(=O)NC(C)(C)C)N1CC1=CC=CN=C1 CBVCZFGXHXORBI-PXQQMZJSSA-N 0.000 abstract 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 238000010992 reflux Methods 0.000 description 7
- 239000007787 solid Substances 0.000 description 6
- 238000001035 drying Methods 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 238000000605 extraction Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000006184 cosolvent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- LOPKSXMQWBYUOI-UHFFFAOYSA-N 1-amino-2,3-dihydro-1h-inden-2-ol Chemical compound C1=CC=C2C(N)C(O)CC2=C1 LOPKSXMQWBYUOI-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/10—Separation; Purification; Stabilisation; Use of additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL1006305A NL1006305C2 (nl) | 1997-06-13 | 1997-06-13 | Werkwijze voor de bereiding van (1S,2R)-1-amino-2-indanol-(R,R)-tartraat methanol solvaat. |
| EP98201879A EP0890571B1 (de) | 1997-06-13 | 1998-06-05 | Verfahren zur Herstellung von (1S,2R)-1-Amino-2-indanol-(R,R)-tartrate methanol Solvat |
| DE69803636T DE69803636T2 (de) | 1997-06-13 | 1998-06-05 | Verfahren zur Herstellung von (1S,2R)-1-Amino-2-indanol-(R,R)-tartrate methanol Solvat |
| AT98201879T ATE212615T1 (de) | 1997-06-13 | 1998-06-05 | Verfahren zur herstellung von (1s,2r)-1-amino-2- indanol-(r,r)-tartrate methanol solvat |
| IL12484098A IL124840A0 (en) | 1997-06-13 | 1998-06-10 | Process for the preparation of (1s,2r)-1-amino-2- indanol-(r,r)-tartrate methanol solvate |
| CA002240305A CA2240305A1 (en) | 1997-06-13 | 1998-06-11 | Process for the preparation of (1s,2r)-1-amino-2-indanol-(r,r)-tartrate methanol solvate |
| JP10199421A JPH1180099A (ja) | 1997-06-13 | 1998-06-11 | （１ｓ，２ｒ）−１−アミノ−２−インダノール−（ｒ，ｒ）−タートレート メタノール溶媒和物の調製方法 |
| CN98102925A CN1203224A (zh) | 1997-06-13 | 1998-06-12 | 制备(1s,2r)－1－氨基－2－二氢化茚醇－(r,r)－酒石酸酯甲醇溶剂化物的方法 |
| US09/095,932 US6586634B1 (en) | 1997-06-13 | 1998-06-12 | Process for the preparation on (1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL1006305A NL1006305C2 (nl) | 1997-06-13 | 1997-06-13 | Werkwijze voor de bereiding van (1S,2R)-1-amino-2-indanol-(R,R)-tartraat methanol solvaat. |
| NL1006305 | 1997-06-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL1006305C2 true NL1006305C2 (nl) | 1998-12-15 |
Family
ID=19765156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL1006305A NL1006305C2 (nl) | 1997-06-13 | 1997-06-13 | Werkwijze voor de bereiding van (1S,2R)-1-amino-2-indanol-(R,R)-tartraat methanol solvaat. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6586634B1 (de) |
| EP (1) | EP0890571B1 (de) |
| JP (1) | JPH1180099A (de) |
| CN (1) | CN1203224A (de) |
| AT (1) | ATE212615T1 (de) |
| CA (1) | CA2240305A1 (de) |
| DE (1) | DE69803636T2 (de) |
| IL (1) | IL124840A0 (de) |
| NL (1) | NL1006305C2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4889501B2 (ja) * | 2004-10-20 | 2012-03-07 | 田辺三菱製薬株式会社 | フェニルエタノールアミン化合物の製造方法及びその中間体 |
| US9227911B2 (en) * | 2012-08-31 | 2016-01-05 | Sumitomo Chemical Company, Limited | Method for producing (R)-1, 1, 3-trimethyl-4-aminoindane |
| CN105061228A (zh) * | 2015-08-26 | 2015-11-18 | 吴玲 | 一种制备r-6-羟基-1-氨基茚满的方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5420353A (en) * | 1994-03-11 | 1995-05-30 | Merck & Co., Inc. | Regiospecific process to make cis-1-amino-2-alkanol from epoxide |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4136605A1 (de) | 1991-11-07 | 1993-05-13 | Philips Patentverwaltung | Verstaerker |
| US5449830A (en) * | 1994-03-11 | 1995-09-12 | Marck & Co., Inc. | Regiospecific processes to make CIS-1-Amino-2-Alkanol from Diol or Halohydrin |
| US5618937A (en) * | 1995-03-15 | 1997-04-08 | Merck & Co., Inc. | Process to make HIV protease inhibitor from (2S)-4-picolyl-2-piperazine-t-butylcarboxamide |
| US5612484A (en) * | 1995-05-18 | 1997-03-18 | Merck & Co., Inc. | Process for making HIV protease inhibitors |
| US5605819A (en) * | 1995-05-19 | 1997-02-25 | Merck & Co., Inc. | Quantitative conversion of indene to (1S,2R) indene oxide and (1S,2R)-indandiol by combination of haloperoxidase bioconversion and chemical steps |
-
1997
- 1997-06-13 NL NL1006305A patent/NL1006305C2/nl not_active IP Right Cessation
-
1998
- 1998-06-05 AT AT98201879T patent/ATE212615T1/de not_active IP Right Cessation
- 1998-06-05 EP EP98201879A patent/EP0890571B1/de not_active Expired - Lifetime
- 1998-06-05 DE DE69803636T patent/DE69803636T2/de not_active Expired - Fee Related
- 1998-06-10 IL IL12484098A patent/IL124840A0/xx unknown
- 1998-06-11 CA CA002240305A patent/CA2240305A1/en not_active Abandoned
- 1998-06-11 JP JP10199421A patent/JPH1180099A/ja active Pending
- 1998-06-12 US US09/095,932 patent/US6586634B1/en not_active Expired - Fee Related
- 1998-06-12 CN CN98102925A patent/CN1203224A/zh active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5420353A (en) * | 1994-03-11 | 1995-05-30 | Merck & Co., Inc. | Regiospecific process to make cis-1-amino-2-alkanol from epoxide |
Also Published As
| Publication number | Publication date |
|---|---|
| DE69803636T2 (de) | 2002-09-05 |
| CA2240305A1 (en) | 1998-12-13 |
| US6586634B1 (en) | 2003-07-01 |
| CN1203224A (zh) | 1998-12-30 |
| EP0890571A1 (de) | 1999-01-13 |
| EP0890571B1 (de) | 2002-01-30 |
| IL124840A0 (en) | 1999-01-26 |
| ATE212615T1 (de) | 2002-02-15 |
| DE69803636D1 (de) | 2002-03-14 |
| JPH1180099A (ja) | 1999-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001509134A (ja) | 低温イオン性液体および長鎖アルキル化剤を使用した直鎖アルキルベンゼンの製造 | |
| NL1006305C2 (nl) | Werkwijze voor de bereiding van (1S,2R)-1-amino-2-indanol-(R,R)-tartraat methanol solvaat. | |
| EP1990333A1 (de) | Verfahren zur Herstellung von Cinacalcethydrochlorid | |
| EP0543874B2 (de) | Restgehaltverminderung von freiem alkylierungsmittel in wässrigen lösungen | |
| BR112017013634B1 (pt) | método para a produção industrial de 2-halo-4,6-dialcoxi-1,3,5-triazina e seu uso na presença de aminas | |
| CN101171251A (zh) | 氨曲南的制备方法 | |
| RU2095981C1 (ru) | Сельскохозяйственная твердая инсектицидная композиция и способ получения твердой инсектицидной композиции | |
| DE69829188T2 (de) | Supernukleophile in 4-stellung substituierte pyridinkatalysatoren und verfahren die nützlich zu deren herstellung sind | |
| DE2442845A1 (de) | Verfahren zum razemisieren von optisch aktiven aminen | |
| EP1265856B1 (de) | Neues verfahren zur herstellung von alpha-(2-4-disulfophenyl)-n-tert-butylnitron und seine pharmazeutisch akzeptierbaren salze | |
| US2794701A (en) | Ammonium nitrate of reduced tendency to caking and setting on storage and method of producing same | |
| CN110078614A (zh) | 己二酸组合物 | |
| BE1000129A3 (fr) | Composants de catalyseurs pour catalyseurs de polymerisation d'alpha-olefines, et procede pour les fabriquer. | |
| US4611077A (en) | Increasing enantiomeric selectivity in chiral cyanohydrination | |
| US3575974A (en) | 7-hydroxylamino-1,3,5-triazaadamantane and its production | |
| CN1205167C (zh) | 2－羟基萘－3－羧酸的结晶及其制造方法 | |
| JP2004513086A5 (de) | ||
| DE3779601T2 (de) | Saure katalysatoren und verfahren zur verwendung. | |
| JP5025067B2 (ja) | テトラヒドロ−３，５−ジメチル−１，３，５−チアジアジン−２−チオンの粒子状調製物の製造方法 | |
| US6300510B1 (en) | Iron alkali salt of S,S-ethylenediamine-N,N′-disuccinic acid and process for producing the same | |
| CN1172905C (zh) | 生产氰基苄胺盐的方法 | |
| DE68924447T2 (de) | Steigerung der optischen Reinheit von 2-(4-aryloxy-phenoxy)propansäuren durch Kristallisation als Hydrate. | |
| JP2000509064A (ja) | 有機塩基のフルオロスルホン酸水素塩、有機塩基のフッ化水素酸塩から有機塩基を遊離させるためのそれらの使用、それらの調製方法、及びそれらを含む組成物 | |
| JP2520458B2 (ja) | アミノアセトニトリル類の安定化法 | |
| JP2003519679A (ja) | α−（２−４−ジスルホフェニル）−Ｎ−ｔｅｒｔ−ブチルニトロン及びその医薬上許容しうる塩の新規な製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PD2B | A search report has been drawn up | ||
| VD1 | Lapsed due to non-payment of the annual fee |
Effective date: 20020101 |